Articles dans des revues avec comité de lecture (58)
  1. 24. Taton, O., Papleux, E., Bondue, B., Knoop, C., Van Laethem, S., Bauler, A., Martiny, D., Montesinos Hernandez, I., Delforge, M.-L., Elmaouhab, K., & Leduc, D. (2020). Role of the Bronchoalveolar Lavage in Noncritically Ill Patients during the SARS-CoV-2 Epidemic. Pulmonary Medicine, 2020, 9012187. doi:10.1155/2020/9012187
  2. 25. Rinciog, C., Diamantopoulos, A., Gentilini, A., Bondue, B., Dahlqvist, C., Froidure, A., Wuyts, A., & Soulard, L. (2020). Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium. PharmacoEconomics - open. doi:10.1007/s41669-019-00191-w
  3. 26. Flaherty, K. R., Wells, A. U., Cottin, V., Devaraj, A., Walsh, S. L. F., Inoue, Y., Richeldi, L., Kolb, M., Tetzlaff, K., Stowasser, S., Coeck, C., Clerisme-Beaty, E., Rosenstock, B., Quaresma, M., Haeufel, T., Goeldner, R. G., Schlenker-Herceg, R., INSTAGE Investigator, B. B., Bondue, B., & Brown, K. (2019). Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. The New England journal of medicine, 381(18), 1718-1727. doi:10.1056/NEJMoa1908681
  4. 27. Wuyts, W., Dahlqvist, C., Slabbynck, H., Schlesser, M., Gusbin, N., Compere, C., Maddens, S., Lee, Y. C., Kirchgaessler, K. U., Bartley, K., & Bondue, B. (2019). Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: The PROOF registry. Respiratory research, 20(1), 231. doi:10.1186/s12931-019-1182-z
  5. 28. Moor, C. C., Wijsenbeek, M. S., Balestro, E., Biondini, D., Bondue, B., Cottin, V., Flewett, R., Galvin, L., Jones, S., Molina-Molina, M., Planas-Cerezales, L., Prasse, A., Prosch, H., Russell, A.-M., Viegas, M., Wanke, G., Wuyts, W., Kreuter, M., & Bonella, F. (2019). Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey. ERJ Open Research, 5(4). doi:10.1183/23120541.00124-2019
  6. 29. Distler, O., Highland, K. B., Gahlemann, M., Azuma, A., Fischer, A., Mayes, M. M., Raghu, G., Sauter, W., Girard, M., Alves, M., Clerisme-Beaty, E., Stowasser, S., Tetzlaff, K., Kuwana, M., SENSCIS Trial Investigators, B. B., Bondue, B., & Maher, T. T. (2019). Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease. The New England journal of medicine, 380(26), 2518-2528. doi:10.1056/NEJMoa1903076
  7. 30. Taton, O., Bondue, B., Sokolow, Y., Mekinda Ngono, Z. L., Ruiz Patino, M. J., Vander Kuylem, M., Remmelink, M., & Leduc, D. (2019). Cryobiopsie endobronchique associée à la navigation électromagnétique peropératoire pour guider la résection chirurgicale des nodules pulmonaires périphériques de petite taille. Revue médicale de Bruxelles, 40(3), 180-183. doi:10.30637/2019.18-086
  8. 31. Loyez, M., Larrieu, J.-C., Chevineau, S., Remmelink, M., Leduc, D., Bondue, B., Lambert, P., Devière, J., Wattiez, R., & Caucheteur, C. (2019). In situ cancer diagnosis through online plasmonics. Biosensors & bioelectronics, 131, 104-112. doi:10.1016/j.bios.2019.01.062
  9. 32. Bondue, B., Castiaux, A., Van Simaeys, G., Mathey, C., Sherer, F., Egrise, D., Lacroix, S., Huaux, F., Doumont, G., & Goldman, S. (2019). Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients. Respiratory research, 20(1), 10. doi:10.1186/s12931-019-0974-5
  10. 33. Maher, T. T., Stowasser, S., Nishioka, Y., White, E., Cottin, V., Noth, I., Selman, M., Rohr, K. B., Michael, A., Ittrich, C., Diefenbach, C., INMARK Trial Investigators, B. B., Bondue, B., & Jenkins, R. G. (2019). Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis Given Nintedanib (INMARK Study): A Randomised, Placebo-Controlled Study. The Lancet. Respiratory medicine, 7(9), 771-779.
  11. 34. Wuyts, W., Wijsenbeek, M., Bondue, B., Bouros, D., Bresser, P., Robalo Cordeiro, C., Hilberg, O., Magnusson, J., Manali, E. E., Morais, A., Papiris, S., Shaker, S., Veltkamp, M., & Bendstrup, E. (2019). Idiopathic pulmonary fibrosis: Best practice in monitoring and managing a relentless fibrotic disease. Respiration. doi:10.1159/000504763
  12. 35. Castiaux, A., Van Simaeys, G., Goldman, S., & Bondue, B. (2018). Assessment of 18F-FDG uptake in idiopathic pulmonary fibrosis: influence of lung density changes. European journal of hybrid imaging.
    13. << Précédent 1 2 3 4 5 6 Suivant >>